PHILADELPHIA, PA—For patients with obesity who are undergoing electrical cardioversion for atrial fibrillation (AF), delivering twice the energy with a simultaneous dual approach is a better option ...
ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
I recently diagnosed atrial fibrillation in a 24-year-old man with new-onset chest pain, irregular palpitations, and heart rate >170 beats per minute. The patient has no history of drug or tobacco ...
All the selected patients for the study were under antiarrhythmic drug treatment (amiodarone 200 mg/day) before the procedure and during the whole follow-up after ECV. Moreover, all of them were also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results